Jane Street’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-105,163
Closed -$1.95M 12566
2026
Q1
$1.95M Buy
105,163
+79,505
+310% +$1.5M ﹤0.01% 5135
2025
Q4
$377K Buy
+25,658
New +$411K ﹤0.01% 8325
2025
Q2
Sell
-31,106
Closed -$859K 10426
2025
Q1
$859K Buy
31,106
+24,821
+395% +$953K ﹤0.01% 5856
2024
Q4
$331K Buy
+6,285
New +$393K ﹤0.01% 7576

Other funds holding MRNY

Jane Street's MRNY Position: Q2 2026 in Review

Jane Street sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026, closing a stake of 105,163 shares — an estimated $1.95M sold.

Jane Street first reported a position in MRNY in Q4 2024 and held it in 4 quarters. The position peaked at $1.95M in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Jane Street reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 105,163 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $1.95M.
  • Jane Street first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2024 and held it in 4 quarters.
  • Jane Street's YieldMax MRNA Option Income Strategy ETF position peaked at $1.95M in Q1 2026.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.